SEC Form 4 · accession 0001562180-18-002453
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Federici
Officer — Sr. VP & CFO
Period of report
May 9, 2018
Accepted (ET)
May 11, 2018 · 3:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2018 | M | 52,000 | $16.045 | A | 247,019 | D | |
| Common StockF1 | May 9, 2018 | S | 52,000 | $87.14 | D | 195,019 | D | |
| Common Stock | holding | — | — | — | 1,046 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 17,061 | I | By Nonqualified Deferred Comp Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $16.045 | May 9, 2018 | M | 52,000 | D | — | Feb 24, 2019 | Common Stock | 52,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $86.95 USD to $87.80 USD; the price reported above reflects the weighted average sale price.
- F2This award vests in 4 equal annual installments beginning on 2/24/2010.